| scholarly article | Q13442814 |
| P2093 | author name string | N Ogasawara | |
| T Mizushima | |||
| M Sasaki | |||
| T Joh | |||
| Y Funaki | |||
| K Kasugai | |||
| N Okaniwa | |||
| P2860 | cites work | Therapeutic effect of lecithinized superoxide dismutase against colitis. | Q54511985 |
| Guidelines for the management of inflammatory bowel disease in adults | Q22242049 | ||
| Inflammatory bowel disease in Asia: A systematic review | Q22242420 | ||
| Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease | Q22251082 | ||
| TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide | Q24801671 | ||
| Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodeling | Q27308984 | ||
| T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm | Q28198949 | ||
| Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice | Q28209975 | ||
| Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences | Q29617565 | ||
| Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. | Q30322266 | ||
| Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice | Q33261882 | ||
| Enzymatic function of nitric oxide synthases | Q33847576 | ||
| Nutrition and diet in inflammatory bowel disease. | Q34035432 | ||
| Endothelial nitric oxide synthase transgenic models of endothelial dysfunction | Q34286604 | ||
| Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking | Q34310387 | ||
| Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice | Q35098405 | ||
| Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients | Q35150494 | ||
| Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease | Q35357996 | ||
| Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis | Q35991096 | ||
| eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage | Q36302954 | ||
| Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase | Q37388154 | ||
| Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy | Q37795103 | ||
| Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina. | Q38306994 | ||
| Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis | Q39888591 | ||
| Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines | Q42464997 | ||
| eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization | Q42511987 | ||
| The fatty acid profile of the erythrocyte membrane in initial-onset inflammatory bowel disease patients | Q43944807 | ||
| The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells | Q44134020 | ||
| The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis | Q44370384 | ||
| Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation | Q44507322 | ||
| Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury | Q44582179 | ||
| Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. | Q45242450 | ||
| Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression | Q46716874 | ||
| Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility | Q47712463 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 35-44 | |
| P577 | publication date | 2014-11-12 | |
| P1433 | published in | Free Radical Research | Q5500025 |
| P1476 | title | eNOS plays an important role in the regulation of colonic inflammation: a novel therapeutic target and a predictive marker for the prognosis of ulcerative colitis | |
| P478 | volume | 49 |
| Q51327691 | Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease. |
| Q41087764 | Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-κB and NOS/NO signaling pathways |
| Q96229726 | Serum adropin levels are reduced in patients with inflammatory bowel diseases |
| Q33599021 | The solid-state fermentation of Artemisia capillaris leaves with Ganoderma lucidum enhances the anti-inflammatory effects in a model of atopic dermatitis. |
Search more.